medtech matters

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶ECRI's 2026 Top 10 Health Technology HazardsMedtech Matters57:26
   +Listen later
2. 2▶Measuring Regulatory/Quality Team Member PerformanceMedtech Matters1:02:20
   +Listen later
3. 3▶FDA's Third-Party Review ProgramMedtech Matters1:01:00
   +Listen later
4. 4▶Triaging Your QMS: Considerations Based on the New QMSRMedtech Matters59:19
   +Listen later
5. 5▶A Deep Dive into E&L and Biocomp TestingMedtech Matters22:09
   +Listen later
6. 6▶Planning for FDA Shutdowns Now and in the FutureMedtech Matters57:28
   +Listen later
7. 7▶Should Wellness Products Come with a Warning?Medtech Matters1:06:02
   +Listen later
8. 8▶3 Most Common Premarket (Postmarket?) Review Issues FDA SeesMedtech Matters53:16
   +Listen later
9. 9▶Why Are One-Third of MAUDE Reports a Problem?Medtech Matters58:10
   +Listen later
10. 10▶FDA Guidance on Off-Label Communication, Part 2Medtech Matters57:13
    +Listen later